Return of Benefit to Society of Publicly Funded Innovations to Combat COVID-19
In response to the COVID-19 pandemic, significant public funds have been invested worldwide into the research, development, and manufacturing of pharmaceutical products to combat the novel coronavirus. Traditionally, intellectual property (IP) rights have been justified in the pharmaceutical sector...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
SAGE Publishing
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3c325e7f15c64ba1b3d4d978dde48b92 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|